Logo image of BRYN.DE

BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) Stock Fundamental Analysis

Europe - FRA:BRYN - US0846707026 - Common Stock

416.25 EUR
+4.6 (+1.12%)
Last: 9/17/2025, 5:27:16 PM
Fundamental Rating

5

BRYN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 46 industry peers in the Financial Services industry. BRYN has only an average score on both its financial health and profitability. BRYN is valued quite cheap, while showing a decent growth score. This is a good combination! This makes BRYN very considerable for value investing!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

BRYN had positive earnings in the past year.
In the past year BRYN had a positive cash flow from operations.
BRYN had positive earnings in 4 of the past 5 years.
Each year in the past 5 years BRYN had a positive operating cash flow.
BRYN.DE Yearly Net Income VS EBIT VS OCF VS FCFBRYN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B 60B 80B

1.2 Ratios

Looking at the Return On Assets, with a value of 5.41%, BRYN is in the better half of the industry, outperforming 73.91% of the companies in the same industry.
BRYN's Return On Equity of 9.42% is in line compared to the rest of the industry. BRYN outperforms 58.70% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.37%, BRYN is in line with its industry, outperforming 52.17% of the companies in the same industry.
BRYN had an Average Return On Invested Capital over the past 3 years of 4.13%. This is significantly below the industry average of 10.06%.
The 3 year average ROIC (4.13%) for BRYN is below the current ROIC(4.37%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.41%
ROE 9.42%
ROIC 4.37%
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
BRYN.DE Yearly ROA, ROE, ROICBRYN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

BRYN has a Profit Margin of 17.00%. This is in the better half of the industry: BRYN outperforms 65.22% of its industry peers.
BRYN's Profit Margin has declined in the last couple of years.
The Operating Margin of BRYN (15.70%) is comparable to the rest of the industry.
BRYN's Operating Margin has improved in the last couple of years.
BRYN has a worse Gross Margin (16.97%) than 65.22% of its industry peers.
In the last couple of years the Gross Margin of BRYN has grown nicely.
Industry RankSector Rank
OM 15.7%
PM (TTM) 17%
GM 16.97%
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
BRYN.DE Yearly Profit, Operating, Gross MarginsBRYN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BRYN is still creating some value.
The number of shares outstanding for BRYN has been reduced compared to 1 year ago.
Compared to 5 years ago, BRYN has less shares outstanding
The debt/assets ratio for BRYN has been reduced compared to a year ago.
BRYN.DE Yearly Shares OutstandingBRYN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
BRYN.DE Yearly Total Debt VS Total AssetsBRYN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B 1T

2.2 Solvency

Based on the Altman-Z score of 1.43, we must say that BRYN is in the distress zone and has some risk of bankruptcy.
BRYN has a Altman-Z score (1.43) which is comparable to the rest of the industry.
The Debt to FCF ratio of BRYN is 15.44, which is on the high side as it means it would take BRYN, 15.44 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 15.44, BRYN is doing worse than 65.22% of the companies in the same industry.
BRYN has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
BRYN has a Debt to Equity ratio of 0.19. This is in the better half of the industry: BRYN outperforms 63.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 15.44
Altman-Z 1.43
ROIC/WACC1.36
WACC3.22%
BRYN.DE Yearly LT Debt VS Equity VS FCFBRYN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

2.3 Liquidity

A Current Ratio of 1.95 indicates that BRYN should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.95, BRYN is in the better half of the industry, outperforming 73.91% of the companies in the same industry.
A Quick Ratio of 1.68 indicates that BRYN should not have too much problems paying its short term obligations.
The Quick ratio of BRYN (1.68) is better than 76.09% of its industry peers.
Industry RankSector Rank
Current Ratio 1.95
Quick Ratio 1.68
BRYN.DE Yearly Current Assets VS Current LiabilitesBRYN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B

4

3. Growth

3.1 Past

BRYN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.24%, which is quite good.
BRYN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.78% yearly.
Looking at the last year, BRYN shows a small growth in Revenue. The Revenue has grown by 0.01% in the last year.
The Revenue has been growing slightly by 7.84% on average over the past years.
EPS 1Y (TTM)8.24%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%-3.87%
Revenue 1Y (TTM)0.01%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%-1.22%

3.2 Future

The Earnings Per Share is expected to grow by 2.26% on average over the next years.
The Revenue is expected to grow by 4.89% on average over the next years.
EPS Next Y-3.47%
EPS Next 2Y0.07%
EPS Next 3Y2.03%
EPS Next 5Y2.26%
Revenue Next Year0.77%
Revenue Next 2Y0.48%
Revenue Next 3Y1.6%
Revenue Next 5Y4.89%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BRYN.DE Yearly Revenue VS EstimatesBRYN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 100B 200B 300B 400B
BRYN.DE Yearly EPS VS EstimatesBRYN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10K 20K 30K

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 0.02 indicates a rather cheap valuation of BRYN.
Compared to the rest of the industry, the Price/Earnings ratio of BRYN indicates a rather cheap valuation: BRYN is cheaper than 100.00% of the companies listed in the same industry.
BRYN is valuated cheaply when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 0.01, the valuation of BRYN can be described as very cheap.
BRYN's Price/Forward Earnings ratio is rather cheap when compared to the industry. BRYN is cheaper than 100.00% of the companies in the same industry.
BRYN is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.70, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 0.02
Fwd PE 0.01
BRYN.DE Price Earnings VS Forward Price EarningsBRYN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

BRYN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BRYN is cheaper than 97.83% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BRYN is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.09
EV/EBITDA 0.34
BRYN.DE Per share dataBRYN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100K 200K 300K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0
EPS Next 2Y0.07%
EPS Next 3Y2.03%

0

5. Dividend

5.1 Amount

BRYN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BERKSHIRE HATHAWAY INC-CL B

FRA:BRYN (9/17/2025, 5:27:16 PM)

416.25

+4.6 (+1.12%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)08-02 2025-08-02/bmo
Earnings (Next)10-31 2025-10-31
Inst Owners33.77%
Inst Owner ChangeN/A
Ins Owners36.68%
Ins Owner ChangeN/A
Market Cap599.40M
Analysts80
Price Target453.75 (9.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.8%
Min EPS beat(2)-9.78%
Max EPS beat(2)0.19%
EPS beat(4)2
Avg EPS beat(4)5.7%
Min EPS beat(4)-10.41%
Max EPS beat(4)42.8%
EPS beat(8)6
Avg EPS beat(8)8.53%
EPS beat(12)8
Avg EPS beat(12)6.49%
EPS beat(16)11
Avg EPS beat(16)7.41%
Revenue beat(2)0
Avg Revenue beat(2)-3.21%
Min Revenue beat(2)-4.09%
Max Revenue beat(2)-2.33%
Revenue beat(4)0
Avg Revenue beat(4)-3.53%
Min Revenue beat(4)-7.69%
Max Revenue beat(4)-0.01%
Revenue beat(8)3
Avg Revenue beat(8)-1.26%
Revenue beat(12)4
Avg Revenue beat(12)-0.85%
Revenue beat(16)5
Avg Revenue beat(16)-1.25%
PT rev (1m)-1.63%
PT rev (3m)-3.82%
EPS NQ rev (1m)2.89%
EPS NQ rev (3m)13.05%
EPS NY rev (1m)2.72%
EPS NY rev (3m)2.36%
Revenue NQ rev (1m)-0.61%
Revenue NQ rev (3m)-2.37%
Revenue NY rev (1m)3.38%
Revenue NY rev (3m)-0.85%
Valuation
Industry RankSector Rank
PE 0.02
Fwd PE 0.01
P/S 0
P/FCF 0.09
P/OCF 0.03
P/B 0
P/tB 0
EV/EBITDA 0.34
EPS(TTM)26753.68
EY6427.31%
EPS(NY)27982.01
Fwd EY6722.4%
FCF(TTM)4837.64
FCFY1162.2%
OCF(TTM)16122.7
OCFY3873.32%
SpS217709.24
BVpS392886.64
TBVpS322648
PEG (NY)N/A
PEG (5Y)0
Profitability
Industry RankSector Rank
ROA 5.41%
ROE 9.42%
ROCE 5.42%
ROIC 4.37%
ROICexc 4.82%
ROICexgc 5.84%
OM 15.7%
PM (TTM) 17%
GM 16.97%
FCFM 2.22%
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
ROICexc(3y)4.31%
ROICexc(5y)3.94%
ROICexgc(3y)5.19%
ROICexgc(5y)4.78%
ROCE(3y)5.11%
ROCE(5y)4.61%
ROICexcg growth 3Y9.15%
ROICexcg growth 5Y4.04%
ROICexc growth 3Y9.9%
ROICexc growth 5Y4.98%
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
F-Score4
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 15.44
Debt/EBITDA 1.78
Cap/Depr 146.66%
Cap/Sales 5.18%
Interest Coverage 11.47
Cash Conversion 38.5%
Profit Quality 13.07%
Current Ratio 1.95
Quick Ratio 1.68
Altman-Z 1.43
F-Score4
WACC3.22%
ROIC/WACC1.36
Cap/Depr(3y)148.32%
Cap/Depr(5y)138.32%
Cap/Sales(3y)5.18%
Cap/Sales(5y)5.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.24%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%-3.87%
EPS Next Y-3.47%
EPS Next 2Y0.07%
EPS Next 3Y2.03%
EPS Next 5Y2.26%
Revenue 1Y (TTM)0.01%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%-1.22%
Revenue Next Year0.77%
Revenue Next 2Y0.48%
Revenue Next 3Y1.6%
Revenue Next 5Y4.89%
EBIT growth 1Y6.42%
EBIT growth 3Y18.52%
EBIT growth 5Y13.14%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-68.47%
FCF growth 3Y-23.7%
FCF growth 5Y-12.55%
OCF growth 1Y-36.42%
OCF growth 3Y-8.11%
OCF growth 5Y-4.59%